What is OraSure Technologies Return-on-Tangible-Equity?
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. OraSure Technologies's annualized net income for the quarter that ended in Dec. 2024 was $-43.2 Mil. OraSure Technologies's average shareholder tangible equity for the quarter that ended in Dec. 2024 was $371.1 Mil. Therefore, OraSure Technologies's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2024 was -11.63%.
The historical rank and industry rank for OraSure Technologies's Return-on-Tangible-Equity or its related term are showing as below:
OSUR'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -6.9 Med: 6.52 Max: 16.01
Current: -5.09
During the past 13 years, OraSure Technologies's highest Return-on-Tangible-Equity was 16.01%. The lowest was -6.90%. And the median was 6.52%.
OSUR's Return-on-Tangible-Equity is ranked worse than 59.74% of 760
companies
in the Medical Devices & Instruments industry
Industry Median: 2.36
vs OSUR: -5.09
OraSure Technologies Return-on-Tangible-Equity Historical Data
The historical data trend for OraSure Technologies's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of OraSure Technologies's Return-on-Tangible-Equity
For the Medical Instruments & Supplies subindustry, OraSure Technologies's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OraSure Technologies's Return-on-Tangible-Equity Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, OraSure Technologies's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where OraSure Technologies's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Dec. 2024) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
OraSure Technologies Return-on-Tangible-Equity Related Terms
Thank you for viewing the detailed overview of OraSure Technologies's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
OSUR has been successfully added to your 